Ostrum Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.73M | Sell |
9,488
-56,129
| -86% | -$16.1M | 0.13% | 149 |
|
|
2025
Q1 | $20.2M | Buy |
65,617
+60,040
| +1,077% | +$18.5M | 1.06% | 21 |
|
|
2024
Q4 | $1.97M | Buy |
5,577
+2,727
| +96% | +$962K | 0.17% | 197 |
|
|
2024
Q3 | $1.02M | Sell |
2,850
-8,339
| -75% | -$2.99M | 0.08% | 305 |
|
|
2024
Q2 | $3.56M | Sell |
11,189
-6,688
| -37% | -$2.13M | 0.31% | 78 |
|
|
2024
Q1 | $4.11M | Sell |
17,877
-4,472
| -20% | -$1.03M | 0.32% | 76 |
|
|
2023
Q4 | $4.91M | Sell |
22,349
-6,484
| -22% | -$1.43M | 0.43% | 49 |
|
|
2023
Q3 | $6.51M | Buy |
28,833
+1,366
| +5% | +$309K | 0.6% | 19 |
|
|
2023
Q2 | $6.06M | Sell |
27,467
-1,853
| -6% | -$409K | 0.51% | 34 |
|
|
2023
Q1 | $6.57M | Buy |
+29,320
| New | +$6.57M | 0.57% | 23 |
|